P1078: PATIENTS WITH HODGKIN LYMPHOMA DEVELOP ADEQUATE HUMORAL SEROLOGICAL RESPONSE TO VACCINATION WITH TWO DOSES OF BNT162B2 AND THEIR IGG ANTIBODY LEVELS MARKEDLY INCREASE AFTER...

por Dann, E., Inbar, T., Mashiach, T., Eisa, J., Ringelstein-Harlev, S., Horowitz, N.
Publicado 2022

P1584: CELLULAR IMMUNE RESPONSE TO THE BNT162B2 VACCINE IN LYMPHOMA PATIENTS

por Gurion, R., Rozovski, U., Itchaki, G., Gafter-Gvili, A., Leibovitch, C., Raanani, P., Szwarcwort, M., Taylor-Abigadol, M., Dann, E., Horesh, N., Inbar, T., Tzoran, I., Lavi, N., Bar Haim, E., Cohen, H., Slouzky, I., Azoulay, T., Karmona, M., Ringelstein-Harlev, S., Horowitz, N. A.
Publicado 2022

P1229: RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): REAL-LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES

por Vassilakopoulos, T., Ferhanoglu, B., Horowitz, N. A., Apostolidis, J., Mellios, Z., Kaynar, L., Zektser, M., Symeonidis, A., Piperidou, A., Kalpadaki, C., Akay, O. M., Atalar, S. C., Sayyed, A., Katodritou, E., Leonidopoulou, T., Papageorgiou, S., Tadmor, T., Gutwein, O., Karakatsanis, S., Ganzel, C., Karianakis, G., Isenberg, G., Gainaru, G., Vrakidou, E., Palassopoulou, M., Ozgur, M., Siakantaris, M., Paydas, S., Tsirigotis, P., Tsirogianni, M., Hatzimichael, E., Tuglular, T. F., Chatzidimitriou, C., Liaskas, A., Lefaki, M. A., Kanellias, N., Zikos, P., Koumarianou, A., Gafter-Gvili, A., Angelopoulou, M., Karmiris, T., Gurion, R.
Publicado 2022